Research Article | Open Access
Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride-Induced Hepatic Damaged Rats
Curcuma xanthorrhiza (CX) has been used for centuries in traditional system of medicine to treat several diseases such as hepatitis, liver complaints, and diabetes. It has been consumed as food supplement and “jamu” as a remedy for hepatitis. Hence, CX was further explored for its potential as a functional food for liver related diseases. As such, initiative was taken to evaluate the antioxidant and hepatoprotective potential of CX rhizome. Antioxidant activity of the standardized CX fractions was determined using in vitro assays. Hepatoprotective assay was conducted against carbon tetrachloride- (CCl4-) induced hepatic damage in rats at doses of 125, 250, and 500 mg/kg of hexane fraction. Highest antioxidant activity was found in hexane fraction. In the case of hepatoprotective activity, CX hexane fraction showed significant improvement in terms of a biochemical liver function, antioxidative liver enzymes, and lipid peroxidation activity. Good recovery was observed in the treated hepatic tissues histologically. Hence, the results concluded that CX hexane fraction possessed prominent hepatoprotective activities which might be due to its in vitro antioxidant activity. These findings also support the use of CX as a functional food for hepatitis remedy in traditional medicinal system.
The practice of using natural remedies for the treatment of liver diseases has been historic, starting with the Ayurvedic treatment and extending to the Chinese, European, and other systems of traditional medicines . Currently, medicinal herbs and extracts prepared from the traditional systems have created a major impact in the treatment of liver diseases such as hepatitis, cirrhosis, and loss of appetite . Several herbs are highlighted and have been scientifically investigated for their hepatoprotective effects .
CX has been used for centuries in traditional system of medicine to treat several diseases. In folk medicine, CX is reported to be useful for hepatitis, liver complaints, diabetes, rheumatism, cancer, hypertension, and heart disorders. CX has also shown diuretic, anticancer, anti-inflammatory, antioxidant, antihypertensive, antirheumatic, antihepatotoxic, antidysmenorrheal, antispasmodic, antileucorrhoeal, antibacterial, and antifungal effects. Traditionally, this plant which is available as a herbal drink prevents blood clots and increases the immune system . CX is very often utilized as an ingredient in “jamus” recipe which is a typical Indonesian kind of elixir or liquid remedy . There are several claims that CX has been used for its hepatoprotective purposes in folk medicine. This was supported by lowering of the serum enzyme levels such as alanine aminotransferases (ALT), aspartate aminotransferases (AST), and y-glutamate transferases in cisplastin-induced hepatotoxicity in rats given the CX extract . In addition, the hepatoprotective activity of aqueous extract of CX against β-D-galactosamine-induced liver damage and alcohol has been reported by Lin et al.  and Yasni et al. , respectively. However, there are lacking evidences in relating the antioxidant competence with hepatoprotective properties of this plant. In view of this, the present study was aimed at evaluating the hepatoprotective and antioxidant activity of CX rhizome on rat liver damage by carbon tetrachloride (CCl4) which has the potential to be developed as nutraceutical liver supplement for the well being of consumers.
2. Materials and Methods
2.1. Plant Materials
CX plants were obtained from Johor Plantation, Malaysia. A voucher specimen (11022) was authenticated and deposited at the Herbarium Unit of the School of Biological Sciences, Universiti Sains Malaysia.
2.2. Preparation of the Plant Material
The rhizome portion of CX was purchased in powder form from Chemical Engineering Pilot Plant (CEPP), UTM, Skudai, Johor, Malaysia. The coarsely powdered material (800 g) was macerated with 8 L of absolute ethanol for 72 hours with occasional shaking. The maceration was repeated thrice. The extract was filtered and concentrated at reduced pressure on rotary evaporator resulting in dark yellow colored mass (yield 5.2%) .
2.3. Fractionation of CX Ethanolic Extract
50 g of CX ethanolic extract was suspended in water and partitioned with hexane (15 times), ethyl acetate (EtOAc) (10 times), -BuOH (-butanol), and aqueous fraction, respectively, using a separating funnel. Each fraction was dried under reduced pressure at 40°C to yield 4 different fractions of CX ethanolic extract. Fractionation of CX ethanolic extract was carried out using different solvents, namely, hexane, ethyl acetate, -butanol, and water, respectively. Hexane fraction showed the highest yield of 59.5%, followed by ethyl acetate (39.56%) and water (0.94%). -Butanol fraction did not produce any yield.
2.4. Quality Control and Chemical Characterization of CX Fractions Using Gas Chromatography-Mass Spectrometry
Chemical characterization and quality control of the CX fractions (hexane, ethyl acetate, and water) were performed based on the validated method described by .
2.5. Antioxidant Assay of Standardized CX Fractions
The antioxidant activity of standardized CX fractions was determined using four different assays based on the reported protocols, namely, total phenolics content ; total flavonoids content ; ferric-reducing antioxidant power assay (FRAP) ; di(phenyl)-(2,4,6-trinitrophenyl)iminoazanium (DPPH) scavenging assay ; and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay . For each assay, CX fractions and standards were diluted (1 mg/mL) in methanol. Samples were analyzed in triplicate.
2.6. Hepatoprotective Assay of Standardized CX Hexane Fraction
2.6.1. Preparation of Stock Solution
1% of sodium carboxymethylcellulose (CMC) stock solution was prepared in distilled water to be used as vehicle. CCl4 stock solution was prepared by 1 : 1 dilution using olive oil .
2.6.2. Preparation of Sample and Standard Drug
Standardized CX hexane fraction was obtained from liquid-liquid extraction. This hexane fraction was then filtered and evaporated to dryness. The standardized CX hexane fraction at different doses (125, 250, and 500 mg/kg) and standard hepatoprotective drug, silymarin (100 mg/kg), were dissolved in 1% CMC to be administered orally to the rats, respectively. All the samples were freshly prepared on the day of experiment.
2.6.3. Experimental Animals
Male Sprague Dawley rats (150–200 g) were obtained from the Animal House, Universiti Sains Malaysia. The animals were acclimatized to laboratory conditions for seven days prior to the experiments. Six rats were housed per polycarbonate cage, with free access to food (normal laboratory chow, Gold Coin) and tap water ad libitum. The animals were maintained at room temperature under a light/dark cycle of 12 h. Experimental protocols and procedures employed in this study were approved by the Animal Ethics Committee of the School of Pharmaceutical Sciences, Universiti Sains Malaysia, with the reference number USM/PPSF/50(054) Jld 2.
2.6.4. Experimental Design
Experimental protocol was based on previously reported studies with slight modifications . Animals were divided into six groups, each group containing six rats.(i)Group 1 served as normal control and received only the vehicle (1% CMC) (1 mL/kg/day) orally for seven consecutive days.(ii)Group 2 received a single dose of CCl4 (1 mL/kg) at day 7.(iii)Group 3 was pretreated with standard hepatoprotective drug, silymarin 100 mg/kg, orally for seven consecutive days followed by single oral dose of CCl4 (1 mL/kg) orally at day 7.(iv)Groups 4, 5, and 6 were administered with standardized CX hexane fraction (125, 250, and 500 mg/kg body weight) orally, respectively, for seven consecutive days followed by a single dose of CCl4 (1 mL/kg) orally at day 7.
2.6.5. Biochemical Parameters Examination
Animals were sacrificed 24 h after the last treatment with at least 16 h of overnight fasting. About 1.5 mL of blood was collected via cardiac puncture using a needle (size 0.50 × 16 mm, Terumo) . Blood samples obtained from the rats were allowed to clot at room temperature for 60 min. Then, the clotted blood samples were centrifuged at 3,000 rpm at room temperature for 15 min to obtain the blood serum. The serum was subjected to biochemical tests such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), triglyceride, and total protein (TP) using biochemistry analyzer at Lam Wah Ee Hospital, Penang, Malaysia.
2.6.6. Histopathological Studies
After the animals were sacrificed, postmortem examination was performed according to Tsung et al. . All the organs were sliced into small pieces and preserved in 4% formalin before further treatment. Then the organs were dehydrated using solvents followed by waxing and clearing process. After that, the tissues were dipped into paraffin, cut into 4-5 μm thick sections, and subsequently fixed onto the slides. Finally, samples were stained using hematoxylin-eosin (H & E) and assessed for any tissue damage under photomicroscope.
2.6.7. Antioxidative Enzymes Analysis
Liver homogenates of 10% (w/v) were prepared in an ice cold (4°C) buffer of 0.1 M Tris (hydroxymethyl) aminomethane-HCl (TRIS-HCl), pH 7.4. Using a homogenizer fitted with a teflon pestle the sample was homogenized at 1000 rpm for 2 min. The homogenates were then centrifuged at 1000 rpm at 4°C for 10 min to remove nuclei and debris . The supernatants were stored at −80°C until the time of biochemical analyses including the total protein (TP), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), lipid peroxidation, and malondialdeyde (MDA) tests.
2.6.8. Statistical Analysis
The data are expressed as mean ± S.E.M. To determine whether there is any statistical difference among the various groups of subject, one-way ANOVA analysis was carried out followed by Tukey’s multiple comparison test using SPSS Version 12 software. A value of was considered as statistically significant.
3.1. Standardization of CX Fractions
Figure 1 shows the GC-MS chromatogram of hexane fraction, ethyl acetate fraction, and water fraction. One prominent peak at approximately 9.55 min was observed for all the fractions injected. This peak is attributed to xanthorrhizol, where the identity was confirmed by matching the retention time and mass spectra provided by MS library and purchased marker standard (xanthorrhizol). As for the standardization, the quantitation of xanthorrhizol was based on the peak area calculated from the calibration curve equation (, ) . Xanthorrhizol amount was the highest in hexane fraction (1.8%) followed by ethyl acetate fraction (0.046%) and the least in water fraction (0.03%).
3.2. Antioxidant Activity of Standardized CX Fractions
In general, the hexane fraction of CX was found to have higher phenolics and flavonoids content compared to the ethyl acetate and water fractions (Table 1). Ferric reduction activity of hexane fraction is markedly () higher than that of the ethyl acetate fraction and water fractions, respectively, as shown in Table 2. The potential of CX fractions to scavenge free radicals was assessed by their ability to quench DPPH. The IC50 of the extracts and standards was arranged in the order of increasing magnitude; water < ethyl acetate < hexane < ascorbic acid < morin < rutin < quercetin. As such, hexane fraction of CX displayed the highest antioxidant properties with the IC50 value of mg/mL () compared to the other fractions (Table 2). As for ABTS assay, the results were in similar trend compared to those obtained in the DPPH assay. From the inhibitory concentration (IC50) of the fractions as summarized in Table 2, it was seen that the hexane fraction had the highest ABTS+ radical scavenging activity as shown by the lowest value of IC50.
|Values are presented in mean ± S.E.M (). Different letters indicate significant difference at for hexane and water fractions.|
|Values are presented in mean ± S.E.M (). Different letters indicate significant difference at for different extracts and fractions.|
3.3. Hepatoprotective Activity of Standardized CX Hexane Fraction
3.3.1. Effects of Standardized CX Hexane Fraction on Biochemical Enzymes Analysis in CCl4-Induced Hepatotoxicity Model
The effect of standardized CX hexane fraction on biochemical and enzymes analysis in CCl4-induced hepatotoxicity model in rats is shown in Figure 2. ALT, AST, ALP, triglyceride, and TP were increased significantly by CCl4 administration in all treated groups compared to the normal group. However, treatment with standardized CX hexane fraction at 500 mg/kg for 7 days consecutively decreased the ALT, AST, ALP, triglyceride, and TP levels by 40–80%, respectively.
(a) ALT activity in serum
(b) AST activity in serum
(c) ALP activity in serum
(d) Triglyceride activity in serum
(e) Total protein in serum
3.3.2. Effects of Standardized CX Hexane Fraction on Histopathology Studies in CCl4-Induced Hepatotoxicity in Rats
In control group, normal hepatic cells are characterized by well defined cell linings, prominent nucleus, and prominient central vein surrounded by reticular fibers (Figure 3(a)). On the contrary, massive necrosis formation, hepatocytes ballooning, distortion of hepatocytes, shrinkage of nucleus, clear cell foci formation, loss of cellular boundaries, and reticular fibers were observed in CCl4-intoxicated rats liver section thus indicative of extensive liver injuries (Figure 3(b)). Pretreatment of standardized CX hexane fraction at 125 mg/kg partly prevented hepatoprotective activity. The histopathological changes such as necrosis, ballooning, clear cell foci formation, and structural loss of hepatic lobules were moderate in 250 mg/kg hexane fraction treated groups. However, the histological architecture of liver sections of the rats treated with standardized CX hexane fraction at 500 mg/kg showed almost normal lobular pattern with a mild degree of necrosis, ballooning, clear cell foci, and visible reticular fibers around central vein almost comparable to the control and silymarin treated group (Figures 3(c), 3(d), 3(e), and 3(f)).
3.3.3. Effects of Standardized CX Hexane Fraction on Antioxidative Enzymes in CCl4-Induced Hepatotoxicity in Rats
The effect of single oral dose of CCl4 in rats exhibited significant reduction in TP level and SOD, CAT, GPx, and GR enzyme activities in comparison to the normal (control) group as shown in Figure 4. However, all these enzyme levels were significantly increased by 90% on average at 500 mg/kg of standardized CX hexane fraction. In addition, as illustrated in Figure 4(f), marked inhibition in lipid peroxide (MDA) was observed after pretreatment with standardized CX hexane fraction, and this decrease was recorded at 35.71% in 500 mg/kg treated groups, respectively. The effects of 500 mg/kg of standardized CXRH on the respective enzyme activities were comparable with the silymarin treated group.
(a) Total protein in liver tissue
(b) SOD activity in liver tissue
(c) CAT activity in liver tissue
(d) GPx activity in liver tissue
(e) GR activity in liver tissue
(f) Lipid peroxidation in liver tissue
Production of active radicals, including oxygen free radicals and nonoxygen free radicals, is a well known phenomenon in normal metabolism process. However, excessive free radicals known as reactive oxygen species (ROS) are potential toxic hazards to various biological molecules through lipid peroxidation , DNA damage , and inhibition of protein synthesis . Such damage results in various diseases such as cancer, hepatic injury, arteriosclerosis, and reperfusion injury. In this study, CCl4 was used as the hepatotoxic agent to examine the hepatoprotective properties of CX. The basis of its hepatotoxicity lies in its biotransformation by the cytochrome P450 system to two free radicals, trichloromethyl free radical and trichloromethylperoxy free radical . Since free radicals play such an important role in CCl4-induced hepatotoxicity, plant antioxidants are promising hepatoprotective agents against liver lesion induced by such compounds . In this study, CCl4 treatments could modify liver function, since the activities of ALT, AST, ALP, triglyceride, and TP levels were significantly higher compared to the control group. However, the results showed that pretreatment of rats with CX hexane fraction effectively protected the animals against CCl4-induced hepatic destruction, as evidenced by decreased serum AST, ALT, and ALP, triglycerides, and TP activities. These biochemical findings were further substantiated by histopathological studies which caused a subsequent recovery of liver cells towards normalization. Antioxidant enzymes (SOD, GPx, GR, and catalase (CAT)) represent protection against oxidative tissue damage . CCl4 caused a decrease in GPx, SOD, GR, CAT, and TP activities and increased MDA levels in the liver over those of the control group, implying increased oxidative damage to the liver. However, hexane fraction pretreatment (250 mg/kg and 500 mg/kg) returned the increased MDA and decreased antioxidant enzymes levels back to their control levels, indicating that CX extract may prevent the peroxidation of lipids by CCl4. Following the inhibition of lipid peroxidation or upregulation of the antioxidant enzymes activity, NF-E2-related factor 2 (Nrf2) plays an important role which is highly expressed in detoxification organs, such as liver and kidney. Under normal conditions, Nrf2 is located in the cytoplasm where it forms an inactive complex with its repressor Kelch-like ECH2-associated protein. Upon cell stimulation, Nrf2 dissociates from Keap 1, translocates into the nucleus where it binds to ARE, promotes the expression of Nrf2 target genes, and then increases the effect of antioxidative enzymes, such as CAT, SOD, and GSH-Px . Therefore, upregulation of Nrf2 in nuclear can result in a reduction in the level of the reactive metabolites and, correspondingly, less tissue injury. However, this requires further investigation on the cellular mechanism involved in in vivo regulation of antioxidant enzymes . The possibility of the mechanism of hepatoprotection of CX may be due to its antioxidant action either by scavenging the reactive oxygen molecules or by chemically reducing oxidized compounds as shown in the findings. The high content of major compound, xanthorrhizol, in the CX hexane fraction could be responsible for the antioxidant and hepatoprotective activity but this warrants further investigation to support such a claim. However, the preventive effect of xanthorrhizol on cisplatin-induced hepatotoxicity has been reported in mice in which they attributed the hepatoprotective activity to regulation of gene transcription .
In conclusion, this study heavily supports the use of CX as source of natural antioxidants and as a possible food supplement for a healthy liver, in view of the fact that this plant encompasses hepatoprotective activity. As such, comprehensive investigation on phytochemical studies of CX is a requisite as plant constituents have significant contribution to the overall bioactivity. Further, the promising results from the activity bring supportive data for detailed mechanism studies as well.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
This project was funded by Universiti Sains Malaysia Research University (RU) grant. Sutha Devaraj was supported by USM fellowship from Institute of Postgraduate Studies, Universiti Sains Malaysia.
- R. K. Dhiman and Y. K. Chawla, “Herbal medicines for liver diseases,” Digestive Diseases and Sciences, vol. 50, no. 10, pp. 1807–1812, 2005.
- M. J. Cupp, “Herbal remedies: adverse effects and drug interactions,” American Family Physician, vol. 59, no. 5, pp. 1239–1244, 1999.
- S. Malhotra, A. Singh, and G. Munjal, “Hepatotoxic potential of commonly used herbal products,” Gastroenterology Today, vol. 5, pp. 110–111, 2001.
- A. S. Herman, “Berbagaimacam penggunaan temulawak dalam makanan dan minuman,” in Proceeding of National Symposium on Temulawak, pp. 186–187, Pajajaran University Research Institute, Bandung, Indonesia, 1985.
- L. M. Perry, “Medicinal plants of East and Southeast Asia: attributed properties and uses,” in Handbook of Medicinal Plants, The MIT Press, Cambridge, Mass, USA, 1980.
- S. Hwan Kim, K. Ok Hong, W. Chung, J. Kwan Hwang, and K. Park, “Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription,” Toxicology and Applied Pharmacology, vol. 196, no. 3, pp. 346–355, 2004.
- S. Lin, C. Teng, C. Lin, Y. Lin, and S. Supriyatna, “Protective and therapeutic effect of the indonesian medicinal herb Curcuma xanthorrhiza on α-d galactosamine-induced liver damage,” Phytotherapy Research, vol. 10, no. 2, pp. 131–135, 1996.
- S. Yasni, K. Imaizumi, M. Nakamura, J. Aimoto, and M. Sugano, “Effects of Curcuma xanthorrhiza roxb. and curcuminoids on the level of serum and liver lipids, serum apolipoprotein A-I and lipogenic enzymes in rats,” Food and Chemical Toxicology, vol. 31, no. 3, pp. 213–218, 1993.
- S. Devaraj, A. S. Esfahani, S. Ismail, S. Ramanathan, and M. F. Yam, “Evaluation of the antinociceptive activity and acute oral toxicity of standardized ethanolic extract of the rhizome of curcuma xanthorrhiza roxb,” Molecules, vol. 15, no. 4, pp. 2925–2934, 2010.
- K. Slinkard and V. L. Singleton, “Total phenol analysis: automation and comparison with manual methods,” The American Journal of Enology and Viticulture, vol. 28, no. 1, p. 49, 1977.
- J. Zhishen, T. Mengcheng, and W. Jianming, “The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals,” Food Chemistry, vol. 64, no. 4, pp. 555–559, 1999.
- I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996.
- W. Brand-Williams, M. E. Cuvelier, and C. Berset, “Use of a free radical method to evaluate antioxidant activity,” LWT—Food Science and Technology, vol. 28, no. 1, pp. 25–30, 1995.
- R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology and Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999.
- N. Tirkey, S. Pilkhwal, A. Kuhad, and K. Chopra, “Hasperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney,” BMC Pharmacology, vol. 5, article 2, 2005.
- B. Levine, “Animal clinical pathology,” in CRC Handbook of Toxicology, M. J. Derelanko and M. A. Hollinger, Eds., pp. 517–537, CRC Press, New York, NY, USA, 1995.
- A. Tsung, R. A. Hoffman, K. Izuishi et al., “Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells,” The Journal of Immunology, vol. 175, no. 11, pp. 7661–7668, 2005.
- M. D. Scott, J. W. Eaton, F. A. Kuypers, D. T.-. Chiu, and B. H. Lubin, “Enhancement of erythrocyte superoxide dismutase activity: effects on cellular oxidant defense,” Blood, vol. 74, no. 7, pp. 2542–2549, 1989.
- B. Halliwell and S. Chirico, “Lipid peroxidation: its mechanism, measurement, and significance,” The American Journal of Clinical Nutrition, vol. 57, no. 5, pp. 715–724, 1993.
- B. Halliwell and O. I. Aruoma, “DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems,” FEBS Letters, vol. 281, no. 1-2, pp. 9–19, 1991.
- R. Ilavarasan, M. Vasudevan, S. Anbazhagan, and S. Venkataraman, “Antioxidant activity of Thespesia populnea bark extracts against carbon tetrachloride-induced liver injury in rats,” Journal of Ethnopharmacology, vol. 87, no. 2-3, pp. 227–230, 2003.
- D. H. F. Mak, S. P. Ip, P. C. Li, M. K. T. Poon, and K. M. Ko, “Alterations in tissue glutathione antioxidant system in Streptozotocin-induced diabetic rats,” Molecular and Cellular Biochemistry, vol. 162, no. 2, pp. 153–158, 1996.
- E. Gabele, M. Fron, G. E. Aeteel, T. Uesugi, C. Hellerbrand, and J. Scholmerich, “TNF-alpha is required for cholestasis-induced liver fibrosis in the mouse,” Biochemical and Biophysical Research Communications, vol. 378, no. 3, pp. 348–353, 2009.
Copyright © 2014 Sutha Devaraj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.